ESCO Announces First Quarter Fiscal 2021 Results
COVID-19 Update
“Our Q1 2021 results reflect the importance of maintaining diversity across our end-markets, as this diversity, coupled with our strong balance sheet and substantial liquidity will continue to support our long-term growth. Our multi-segment platform, enabled us to substantially mitigate COVID-19’s impact on sales and earnings, while generating record cash flow during Q1 which allowed us to further reduce our debt and lower our leverage ratio to 0.38x at
“I’m confident that our well-tested operating model and our recent cost reduction actions will position us for solid earnings growth as our end-markets recover. The fundamentals of our portfolio remain strong and our goal remains the same – to create long-term shareholder value.”
Q1 2021 Acquisition
As announced previously, on
Discrete Items
During Q1 2021, the Company incurred
During Q1 2020, the company incurred
Also during Q1 2020, the company completed the sale of its
The financial results presented include certain non-GAAP financial measures such as EBIT, EBITDA, Adjusted EBITDA and Adjusted EPS, as defined within the “Non-GAAP Financial Measures” described below. Any non-GAAP financial measures presented are reconciled to their respective GAAP equivalents.
Management believes these non-GAAP financial measures are useful in assessing the ongoing operational profitability of the Company’s business segments, and therefore, allow shareholders better visibility into the Company’s underlying operations. See “Non-GAAP Financial Measures” described below.
Earnings Summary
Q1 2021 GAAP EPS was
Q1 2020 GAAP EPS was
Q1 2021 Adjusted EBITDA increased 4.4 percent to
Operating Highlights – Q1
- Net sales were
$163 million in Q1 2021, compared to$172 million in Q1 2020. - A&D segment sales decreased
$11 million in Q1 2021, resulting from lower commercial aerospace sales due to COVID-19, partially offset by a$4 million increase in navy and space sales. - Driven by steady chamber project deliveries, Test sales increased to
$42 million in Q1 2021 from$41 million in Q1 2020. - USG sales increased to
$55 million in Q1 2021 compared to$53 million in Q1 2020. The sales increase resulted from an easing of pent-up demand as several utility customers released calendar year-end spending for equipment and software requirements. This partial spending recovery continues to be impacted by the timing of certain project deliverables and maintenance deferrals as utility customers continue to manage around COVID-19’s impact restricting on-site personnel at substations, large transformers and other customer locations. - Gross margin percentage increased to 39.4 percent in Q1 2021 from 37.9 percent in Q1 2020 driven by higher sales in USG coupled with manufacturing cost reduction actions implemented across the company.
- SG&A expenses decreased
$1 million in Q1 2021 compared to Q1 2020 as a result of lower spending on discretionary expenses, including travel, to help offset the negative sales impact from COVID-19. - Non-cash amortization of intangible assets decreased
$1 million in Q1 2021 compared to Q1 2020 resulting from lower software amortization. - Interest expense decreased
$2 million in Q1 2021 compared to Q1 2020 due to the lower amount of debt outstanding. - The effective income tax rate used for determining Adjusted EPS was approximately 23 percent in Q1 2021 and 25 percent in Q1 2020.
- Entered orders were
$158 million in Q1 2021 (book-to-bill of 0.97x) resulting in an ending backlog of$512 million atDecember 31, 2020 . - Q1 2021 net cash provided by operating activities was
$25 million , resulting in a net cash position (total cash on hand, less total borrowings) of$2 million atDecember 31, 2020 reflecting a 0.38x leverage ratio.
Chairman’s Commentary
“Driven by our increased focus on working capital management, the clear highlight in Q1 was the strength of our cash generation which increased our liquidity. Our strong liquidity position will benefit us during 2021 as we continue our pursuit of acquisitions and expand our internal investments in new product development across the company.
“From an operations perspective, USG clearly drove our Q1 2021 success by substantially exceeding our internal expectations on both sales and earnings, as the segment reported an Adjusted EBIT margin of nearly 25 percent, compared to Q1 2020’s Adjusted EBIT margin of 19 percent. USG delivered higher than expected sales as several customers resumed their calendar year-end budget spending which provided additional product and software sales, and resulted in a favorable sales mix.
“While we expect to see some continued deferrals of test equipment purchases and maintenance-related projects for the next few months, our positive outlook for the second half of the year remains the same. Our cost reduction actions implemented in 2020 are also having an impact as shown by USG’s improved operating margins.
“Continuing on the positive side, I’m pleased to see the enthusiasm being generated in the market surrounding several new products and solutions recently introduced at Doble, and we continue to see NRG’s end markets recovering as investments in renewable energy have been increasing in both wind and solar. Our recently introduced solar products have been growing far better than anticipated and we expect that growth to continue.
“The performance of the Test segment remained solid as we increased our EBIT margin to 12.9 percent in Q1 2021, up from 11.3 percent in Q1 2020 on slightly higher sales. While not immune from COVID’s impact, our Test business continues to demonstrate its resilience by delivering consistently solid operating results with increasing margins. We expect Test’s outlook to remain positive given the strength of its served markets, primarily related to new communications technologies such as 5G and our growing shielding business. Our view of 5G’s future is favorable given the size of the investments being made by numerous large, global companies leading its development.
Our A&D segment’s results were generally consistent with our previous sales and EBIT expectations. We anticipated a meaningful decrease in our commercial aerospace businesses resulting from COVID to be partially offset by solid performance from our navy, defense and space businesses. Despite the decline in commercial aerospace sales, A&D’s Adjusted EBIT margin was 15 percent, only slightly down from the 16 percent Adjusted EBIT margin reported in Q1 2020. Maintaining a reasonable operating margin during COVID’s impact reflects the strength of our program, product and end-market diversity, as the navy and defense markets remained strong which partially offset the decline in commercial aerospace. A&D’s operating margins are expected to improve significantly as the commercial aerospace market recovers over time coupled with our resized operating cost structure implemented during 2020’s downturn.
“The defense portion of A&D, both military aerospace and navy products, is expected to remain strong for the foreseeable future given its sizeable backlog coupled with the timing of expected platform deliveries.
“Wrapping up, I’m pleased that we were able to generate substantial cash from operations and increase our Adjusted EBITDA margin to 18 percent, from 16 percent in Q1 2020, despite the lower contribution from our commercial aerospace business.
“Given our strong financial condition, we expect to fund future acquisitions and to organically grow our business through continued investment in new products and solutions. We are currently evaluating a solid pipeline of M&A opportunities as we continue to take a prudent and deliberate approach while evaluating our near-term targets. As end-markets continue to settle down and more clarity appears in our targeted areas, we are confident that we will add to our current portfolio.
“We have positioned ourselves favorably from a cost structure standpoint and we anticipate a gradual return to a more normal operating environment in the second half of 2021. I continue to have a strong, favorable view of our future.”
Dividend Payment
The next quarterly cash dividend of
Planned Retirement of General Counsel – 2021
Business Outlook – 2021 (COVID Uncertainty)
Our current Business Outlook for 2021 is consistent with the commentary included in the Company’s previous earnings release dated
In mid-year 2020, business disruptions related to the pandemic began to affect the Company’s operations and continued throughout the balance of the year. During 2021, the commercial aerospace and utility end-markets have seen some degree of customer stabilization, as well as notable pockets of recovery; however, there is still uncertainty as to the timing and pace of the recovery in these areas.
The wide distribution of viable COVID-19 vaccines is anticipated to benefit and accelerate the recovery of commercial air travel and utility spending with customers resuming normal testing protocols and equipment purchases, but Management has determined that it is advisable to wait at least another 90 days before resuming specific guidance.
Given this uncertainty, it is difficult to predict how the balance of 2021 will be affected using normal forecasting methodologies, therefore, the Company will continue its suspension of forward-looking guidance.
To assist shareholders and analysts, Management will continue offering “directional” guidance for 2021, by stating that the Company is seeing tangible signs of recovery in the second half of fiscal 2021 that point to a solid outlook for the back half of the year.
Given the strength of the first half of 2020 pre-COVID, it is projected that the first half of 2021 will be a slightly lower comparison to 2020’s first half, but the outlook for the second half of 2021 is expected to compare favorably to the second half of 2020 given the anticipated elements of recovery.
Management’s current expectations for 2021 show growth in Sales, Adjusted EBITDA, and Adjusted EPS compared to 2020, with Adjusted EBITDA and Adjusted EPS reasonably consistent with 2019.
Conference Call
The Company will host a conference call today,
Forward-Looking Statements
Statements in this press release regarding the future impacts of COVID-19, including the impact of COVID-19 vaccines on the Company’s results, cost reduction efforts, margins, growth, the financial success of the Company, the strength of its end markets, including without limitation, the timing of expected recovery in selected end markets, growth in the Company’s solar business, delays in test equipment purchases and maintenance-related projects by USG customers, the outlook for the A&D, Test and USG segments, the ability to increase shareholder value, the success of acquisition efforts, internal investments in new products, the long-term success of the Company, and any other statements which are not strictly historical are “forward-looking” statements within the meaning of the safe harbor provisions of the federal securities laws.
Investors are cautioned that such statements are only predictions and speak only as of the date of this release, and the Company undertakes no duty to update them except as may be required by applicable laws or regulations. The Company’s actual results in the future may differ materially from those projected in the forward-looking statements due to risks and uncertainties that exist in the Company’s operations and business environment including but not limited to those described in Item 1A, “Risk Factors”, of the Company’s Annual Report on Form 10-K for the fiscal year ended
Non-GAAP Financial Measures
The financial measures EBIT, EBITDA, Adjusted EBITDA and Adjusted EPS are presented in this press release. The Company defines “EBIT” as earnings before interest and taxes, “EBITDA” as earnings before interest, taxes, depreciation and amortization, “Adjusted EBITDA” as EBITDA excluding certain defined charges, and “Adjusted EPS” as GAAP earnings per share (EPS) excluding the net impact of the items described above which were
EBIT, EBITDA, Adjusted EBITDA and Adjusted EPS are not recognized in accordance with
ESCO, headquartered in
Condensed Consolidated Statements of Operations (Unaudited) | ||||||||||||
(Dollars in thousands, except per share amounts) | ||||||||||||
Three Months Ended 2020 |
Three Months Ended 2019 |
|||||||||||
$ | 162,949 | 171,728 | ||||||||||
Cost and Expenses: | ||||||||||||
Cost of sales | 98,777 | 106,727 | ||||||||||
Selling, general and administrative expenses | 41,000 | 42,105 | ||||||||||
Amortization of intangible assets | 4,948 | 5,810 | ||||||||||
Interest expense | 541 | 2,421 | ||||||||||
Other expenses, net | 23 | 295 | ||||||||||
Total costs and expenses | 145,289 | 157,358 | ||||||||||
Earnings before income taxes | 17,660 | 14,370 | ||||||||||
Income tax expense | 3,974 | 3,606 | ||||||||||
Earnings from continuing operations | 13,686 | 10,764 | ||||||||||
Loss from discontinued operations, net of tax expense | ||||||||||||
(benefit) of |
- | (601 | ) | |||||||||
Gain on sale of discontinued operations, net of | ||||||||||||
tax expense of |
- | 76,614 | ||||||||||
Earnings from discontinued operations | - | 76,013 | ||||||||||
Net earnings | $ | 13,686 | 86,777 | |||||||||
Diluted EPS: | ||||||||||||
Diluted - GAAP | ||||||||||||
Continuing operations | $ | 0.52 | 0.41 | |||||||||
Discontinued operations | 0.00 | 2.91 | ||||||||||
Net earnings | $ | 0.52 | 3.32 | |||||||||
Diluted - As Adjusted Basis | ||||||||||||
Continuing operations | $ | 0.55 | (1 | ) | 0.43 | (2 | ) | |||||
Diluted average common shares |
26,182 | 26,168 | ||||||||||
(1 | ) | Q1 2021 Adjusted EPS excludes |
||||||||||
(2 | ) | Q1 2020 Adjusted EPS excludes |
Condensed Business Segment Information (Unaudited) | |||||||||||||||
(Dollars in thousands) | |||||||||||||||
GAAP | As Adjusted | ||||||||||||||
Q1 2021 | Q1 2020 | Q1 2021 | Q1 2020 | ||||||||||||
Net Sales | |||||||||||||||
Aerospace & Defense | $ | 66,891 | 77,511 | 66,891 | 77,511 | ||||||||||
Test | 41,518 | 41,383 | 41,518 | 41,383 | |||||||||||
USG | 54,540 | 52,834 | 54,540 | 52,834 | |||||||||||
Totals | $ | 162,949 | 171,728 | 162,949 | 171,728 | ||||||||||
EBIT | |||||||||||||||
Aerospace & Defense | $ | 9,380 | 12,513 | 9,700 | 12,583 | ||||||||||
Test | 5,342 | 4,656 | 5,342 | 4,656 | |||||||||||
USG | 12,731 | 9,288 | 13,381 | 9,908 | |||||||||||
Corporate | (9,252 | ) | (9,666 | ) | (9,192 | ) | (9,666 | ) | |||||||
Consolidated EBIT | 18,201 | 16,791 | 19,231 | 17,481 | |||||||||||
Less: Interest expense | (541 | ) | (2,421 | ) | (541 | ) | (2,421 | ) | |||||||
Less: Income tax expense | (3,974 | ) | (3,606 | ) | (4,211 | ) | (3,772 | ) | |||||||
Net earnings from continuing ops | $ | 13,686 | 10,764 | 14,479 | 11,288 | ||||||||||
Note 1: The tables on this page are presented on a continuing operations basis. | |||||||||||||||
Note 2: Adjusted net earnings were |
|||||||||||||||
Note 3: Adjusted net earnings were |
|||||||||||||||
EBITDA Reconciliation to Net earnings: | Q1 2021 | Q1 2020 | |||||||||||||
Q1 2021 | - As Adj | Q1 2020 | - As Adj | ||||||||||||
Consolidated EBITDA | $ | 28,213 | 29,243 | 27,331 | 28,021 | ||||||||||
Less: Depr & Amort | (10,012 | ) | (10,012 | ) | (10,540 | ) | (10,540 | ) | |||||||
Consolidated EBIT | 18,201 | 19,231 | 16,791 | 17,481 | |||||||||||
Less: Interest expense | (541 | ) | (541 | ) | (2,421 | ) | (2,421 | ) | |||||||
Less: Income tax expense | (3,974 | ) | (4,211 | ) | (3,606 | ) | (3,772 | ) | |||||||
Net earnings | $ | 13,686 | 14,479 | 10,764 | 11,288 | ||||||||||
Condensed Consolidated Balance Sheets (Unaudited) | ||||||
(Dollars in thousands) | ||||||
2020 |
2020 |
|||||
Assets | ||||||
Cash and cash equivalents | $ | 57,362 | 52,560 | |||
Accounts receivable, net | 143,675 | 144,082 | ||||
Contract assets | 93,762 | 96,746 | ||||
Inventories | 144,054 | 136,189 | ||||
Other current assets | 13,392 | 17,053 | ||||
Total current assets | 452,245 | 446,630 | ||||
Property, plant and equipment, net | 141,538 | 139,870 | ||||
Intangible assets, net | 347,437 | 346,632 | ||||
411,161 | 408,063 | |||||
Operating lease assets | 20,315 | 21,390 | ||||
Other assets | 10,879 | 10,938 | ||||
$ | 1,383,575 | 1,373,523 | ||||
Liabilities and Shareholders' Equity | ||||||
Current maturities of long-term debt & short-term borrowings | $ | 21,842 | 22,368 | |||
Accounts payable | 44,198 | 50,525 | ||||
Contract liabilities | 112,286 | 100,551 | ||||
Other current liabilities | 76,297 | 82,585 | ||||
Total current liabilities | 254,623 | 256,029 | ||||
Deferred tax liabilities | 60,400 | 60,938 | ||||
Non-current operating lease liabilities | 15,746 | 16,785 | ||||
Other liabilities | 39,207 | 38,176 | ||||
Long-term debt | 34,000 | 40,000 | ||||
Shareholders' equity | 979,599 | 961,595 | ||||
$ | 1,383,575 | 1,373,523 |
Consolidated Statements of Cash Flows (Unaudited) | |||
(Dollars in thousands) | |||
Quarter Ended |
|||
Cash flows from operating activities: | |||
Net earnings | $ | 13,686 | |
Adjustments to reconcile net earnings to net cash | |||
provided by operating activities: | |||
Depreciation and amortization | 10,012 | ||
Stock compensation expense | 1,368 | ||
Changes in assets and liabilities | 264 | ||
Effect of deferred taxes | (538 | ) | |
Net cash provided by operating activities | 24,792 | ||
Cash flows from investing activities: | |||
Acquisition of business, net of cash acquired | (6,508 | ) | |
Capital expenditures | (5,973 | ) | |
Additions to capitalized software | (1,554 | ) | |
Net cash used by investing activities | (14,035 | ) | |
Cash flows from financing activities: | |||
Proceeds from long-term debt | 30,000 | ||
Principal payments on long-term debt and short-term borrowings | (36,526 | ) | |
Dividends paid | (2,083 | ) | |
Net cash used by financing activities | (8,609 | ) | |
Effect of exchange rate changes on cash and cash equivalents | 2,654 | ||
Net increase in cash and cash equivalents | 4,802 | ||
Cash and cash equivalents, beginning of period | 52,560 | ||
Cash and cash equivalents, end of period | $ | 57,362 |
Other Selected Financial Data (Unaudited) | ||||||||||||||
(Dollars in thousands) | ||||||||||||||
Backlog And Entered Orders - Q1 2021 | Aerospace & Defense | Test | USG | Total | ||||||||||
Beginning Backlog - |
$ | 344,661 | 122,032 | 50,688 | 517,381 | |||||||||
Entered Orders | 65,442 | 43,496 | 48,711 | 157,649 | ||||||||||
Sales | (66,891 | ) | (41,518 | ) | (54,540 | ) | (162,949 | ) | ||||||
Ending Backlog - |
$ | 343,212 | 124,010 | 44,859 | 512,081 |
Reconciliation of Non-GAAP Financial Measures (Unaudited) | |||
EPS – Adjusted Basis Reconciliation – Q1 2021 | |||
EPS from Continuing Ops – GAAP Basis – Q1 2021 | $ | 0.52 | |
Adjustments (defined below) | 0.03 | ||
EPS from Continuing Ops – As Adjusted Basis – Q1 2021 | $ | 0.55 | |
Adjustments exclude |
|||
first quarter of 2021. | |||
(The |
|||
offset by |
|||
EPS – Adjusted Basis Reconciliation – Q1 2020 | |||
EPS from Continuing Ops – GAAP Basis – Q1 2020 | $ | 0.41 | |
Adjustments (defined below) | 0.02 | ||
EPS from Continuing Ops – As Adjusted Basis – Q1 2020 | $ | 0.43 | |
Adjustments exclude |
|||
move of the Doble headquarters facility in the first quarter of 2020. | |||
(The |
|||
offset by |
SOURCE
ESCO Technologies Inc.